Transforming Growth Factor (cid:2) Depletion Is the Primary Determinant of Smad Signaling Kinetics (cid:1)
暂无分享,去创建一个
Xuedong Liu | David C. Clarke | Yigong Shi | D. C. Clarke | Xuedong Liu | Yigong Shi | Meredith L. Brown | Richard A Erickson | Richard A. Erickson
[1] E. Bangi,et al. Dual function of the Drosophila Alk1/Alk2 ortholog Saxophone shapes the Bmp activity gradient in the wing imaginal disc , 2006, Development.
[2] J. Gurdon,et al. A quantitative analysis of signal transduction from activin receptor to nucleus and its relevance to morphogen gradient interpretation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Brattain,et al. Heterogeneity of malignant cells from a human colonic carcinoma. , 1981, Cancer research.
[4] H. Lodish,et al. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.
[5] P. Dijke,et al. New insights into TGF-β–Smad signalling , 2004 .
[6] Naama Barkai,et al. Self-enhanced ligand degradation underlies robustness of morphogen gradients. , 2003, Developmental cell.
[7] Xinhua Lin,et al. Drosophila Dpp Morphogen Movement Is Independent of Dynamin-Mediated Endocytosis but Regulated by the Glypican Members of Heparan Sulfate Proteoglycans , 2004, Cell.
[8] K. Kinzler,et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.
[9] Xuedong Liu,et al. Decoding the quantitative nature of TGF-beta/Smad signaling. , 2008, Trends in cell biology.
[10] J. Gurdon,et al. Interpretation of BMP signaling in early Xenopus development. , 2007, Developmental biology.
[11] J. Massagué,et al. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. , 1990, The Journal of biological chemistry.
[12] J. Gurdon,et al. A changing morphogen gradient is interpreted by continuous transduction flow. , 2002, Development.
[13] C. Hill,et al. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.
[14] C. Hill,et al. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. , 2006, Cytokine & growth factor reviews.
[15] Qing Nie,et al. Formation of the BMP activity gradient in the Drosophila embryo. , 2005, Developmental cell.
[16] Xu Cao,et al. GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor , 2004, The Journal of cell biology.
[17] Marcos González-Gaitán,et al. Gradient Formation of the TGF-β Homolog Dpp , 2000, Cell.
[18] T. Muir,et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. , 2001, Molecular cell.
[19] Xueyan Duan,et al. PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling , 2006, Cell.
[20] Bernhard Schmierer,et al. Analysis of Smad nucleocytoplasmic shuttling in living cells , 2004, Journal of Cell Science.
[21] T. Muir. Semisynthesis of proteins by expressed protein ligation. , 2003, Annual review of biochemistry.
[22] Carsten Peterson,et al. A rate equation approach to elucidate the kinetics and robustness of the TGF-beta pathway. , 2006, Biophysical journal.
[23] J. Massagué,et al. Smad transcription factors. , 2005, Genes & development.
[24] Q. Nie,et al. Membrane-Associated Non-Receptors and Morphogen Gradients , 2007, Bulletin of mathematical biology.
[25] D. C. Clarke,et al. Systems theory of Smad signalling. , 2006, Systems biology.
[26] T. Sjöblom,et al. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. , 2008, Oncogene.
[27] J. Smith,et al. Responses of embryonic xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm , 1992, Cell.
[28] Steven Dyson,et al. The Interpretation of Position in a Morphogen Gradient as Revealed by Occupancy of Activin Receptors , 1998, Cell.
[29] C. Heldin,et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.
[30] David Silverstein,et al. Growth factor binding to the pericellular matrix and its importance in tissue engineering. , 2007, Advanced drug delivery reviews.
[31] C. Hill,et al. Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus , 2000, Molecular and Cellular Biology.
[32] Paul A. Bates,et al. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system , 2008, Proceedings of the National Academy of Sciences.
[33] Jeffrey L. Wrana,et al. Early Endosomal Regulation of Smad-dependent Signaling in Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[34] C. Heldin,et al. Characterization of a 60‐kDa cell surface‐associated transforming growth factor‐β binding protein that can interfere with transforming growth factor‐β receptor binding , 1997, Journal of cellular physiology.
[35] Bernhard Schmierer,et al. Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor β-Dependent Nuclear Accumulation of Smads , 2005, Molecular and Cellular Biology.
[36] P. Dijke,et al. Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .
[37] D. Rifkin,et al. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.
[38] Cyrille Alexandre,et al. Regulated Endocytic Routing Modulates Wingless Signaling in Drosophila Embryos , 2001, Cell.
[39] Xinhua Lin,et al. Functions of heparan sulfate proteoglycans in cell signaling during development , 2004, Development.
[40] J. Massagué,et al. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.
[41] R. Pagano,et al. Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11. , 2004, Molecular biology of the cell.
[42] D. Lauffenburger,et al. Receptor‐mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α , 1996, Journal of cellular physiology.
[43] Chris Sander,et al. Signal Processing in the TGF-β Superfamily Ligand-Receptor Network , 2005, PLoS Comput. Biol..
[44] C. Heldin,et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. , 1998, Biochemical and biophysical research communications.
[45] J. Massagué,et al. Internalization of transforming growth factor‐β and its receptor in BALB/c 3T3 fibroblasts , 1986, Journal of cellular physiology.
[46] J. Wrana,et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.
[47] Qing Nie,et al. Do morphogen gradients arise by diffusion? , 2002, Developmental cell.
[48] E Ruoslahti,et al. A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans , 1993, The Journal of cell biology.
[49] James Briscoe,et al. The interpretation of morphogen gradients , 2006, Development.
[50] Jeffrey L. Wrana,et al. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.
[51] A. Moustakas,et al. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer , 2007 .
[52] O. Skalli,et al. On the use of ratio standard curves to accurately quantitate relative changes in protein levels by Western blot. , 2007, Analytical biochemistry.
[53] Luzhe Sun,et al. Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*) , 1995, The Journal of Biological Chemistry.
[54] C. Hill,et al. Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest , 2003, Oncogene.
[55] Tom H. Cheung,et al. Control of cell cycle-dependent degradation of c-Ski proto-oncoprotein by Cdc34 , 2004, Oncogene.
[56] J. Massagué,et al. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. , 1999, Nature.
[57] E. D. De Robertis,et al. Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. , 2005, Genes & development.
[58] L M Wakefield,et al. Distribution and modulation of the cellular receptor for transforming growth factor-beta , 1987, The Journal of cell biology.
[59] M. O’Connor-McCourt,et al. Down-regulation of transforming growth factor-beta receptors: cooperativity between the types I, II, and III receptors and modulation at the cell surface. , 1999, Experimental cell research.
[60] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[61] Bernhard Schmierer,et al. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.
[62] P. Dijke,et al. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF‐β/Smad signalling , 2002, Genes to cells : devoted to molecular & cellular mechanisms.